Task: Answer the multiple-choice question.
Query: Which drug exhibits a 7.027\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CCC1(CC)Cc2ccccc2-c2[nH]c(=S)[nH]c(=O)c21
b) CN(CC(=O)NCC1CCCO1)S(=O)(=O)c1cc(Cl)ccc1Cl
c) CCCNC(=O)NC(=O)CN1CCCC1c1ccc2c(c1)OCCO2
Answer: a. CCC1(CC)Cc2ccccc2-c2[nH]c(=S)[nH]c(=O)c21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1(CC)Cc2ccccc2-c2[nH]c(=S)[nH]c(=O)c21
CCC1(CC)Cc2ccccc2-c2[nH]c(=S)[nH]c(=O)c21
5,5-diethyl-2-sulfanylidene-1,6-dihydrobenzo[h]quinazolin-4-one